WallStreetZenWallStreetZen

NASDAQ: CAPR
Capricor Therapeutics Inc Stock Ownership - Who owns Capricor Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Capricor Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Karimah Es SabarDirector2026-04-027,529$32.00
$240.93kSell
Karimah Es SabarDirector2026-04-027,529$3.18
$23.94kBuy
Karimah Es SabarDirector2026-04-0153,735$4.86
$261.15kBuy
Karimah Es SabarDirector2026-04-0153,735$31.03
$1.67MSell
Karen KrasneyEVP GENERAL COUNSEL2026-03-312,819$3.18
$8.96kBuy
Anthony BergmannCHIEF FINANCIAL OFFICER2026-03-3125,000$3.18
$79.50kBuy
Karimah Es SabarDirector2026-03-3161,265$4.86
$297.75kBuy
Karimah Es SabarDirector2026-03-3161,265$30.17
$1.85MSell
Karen KrasneyEVP GENERAL COUNSEL2026-03-3125,000$30.12
$752.93kSell
Anthony BergmannCHIEF FINANCIAL OFFICER2026-03-3125,000$30.13
$753.15kSell

1 of 2

CAPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAPR insiders and whales buy or sell their stock.

CAPR Shareholders

What type of owners hold Capricor Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nippon Shinyaku Co Ltd12.33%7,090,351$219.16MInsider
Fountainhead Capital Partners Ltd9.65%5,551,000$171.58MInsider
Sinai Medical Center Cedars7.04%4,049,959$125.18MInsider
Eduardo Marban5.75%3,307,863$102.25MInsider
John Edward A. St5.39%3,101,574$95.87MInsider
Louis J. Grasmick5.11%2,937,729$90.81MInsider
Peter M. Kash5.08%2,920,446$90.27MInsider
Blackrock Inc4.96%2,850,978$88.12MInstitution
Wexford Capital LP4.53%2,606,778$80.58MInsider
Vanguard Group Inc4.45%2,561,880$79.19MInstitution

1 of 3

CAPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAPR41.32%58.68%Net BuyingNet Buying
TRVI43.05%56.95%Net Buying
AMLX66.79%33.21%Net SellingNet Selling
RXRX61.48%13.61%Net SellingNet Selling
SION65.07%34.93%Net SellingNet Selling
View Top Biotech Stocks

Capricor Therapeutics Stock Ownership FAQ

Who owns Capricor Therapeutics?

Capricor Therapeutics (NASDAQ: CAPR) is owned by 47.68% institutional shareholders, 67.73% Capricor Therapeutics insiders, and 0.00% retail investors. Nippon Shinyaku Co Ltd is the largest individual Capricor Therapeutics shareholder, owning 7.09M shares representing 12.33% of the company. Nippon Shinyaku Co Ltd's Capricor Therapeutics shares are currently valued at $219.16M.

If you're new to stock investing, here's how to buy Capricor Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.